Lifestyle Intervention for Ovarian Cancer Enhanced Survival

Learn more about using lifestyle interventions to support survivorship. Lifestyle Intervention for Ovarian Cancer Enhanced Survival (LIvES) is the first study to investigate if ovarian cancer survivors can enjoy a longer period of wellbeing through healthful changes in lifestyle and behavior. Read article.

Image Source: Kris Hanning, UAHS BioCommunications, Tracy Crane, PhD (left), and Cynthia Thomson, PhD, RD

Study Shows Acupuncture Decreased Joint Pain in Breast Cancer Patients Treated with Aromatase Inhibitors

Women with early-stage breast cancer treated with aromatase inhibitors had decreased joint pain with acupuncture according to a randomized, multicenter clinical trial led by researchers at NewYork-Presbyterian and Columbia University Irving Medical Center. The study was developed and managed by SWOG and the findings were presented at the San Antonio Breast Cancer Symposium. Read more at NewYork-Presbyterian.

Clinical Trial Shows Benefit of Yoga for Side Effects of Prostate Cancer Treatment

Men who attended a structured yoga class twice a week during prostate cancer radiation treatment reported less fatigue and better sexual and urinary function than those who didn't, according to a clinical trial led by the Perelman School of Medicine at the University of Pennsylvania. Read more from Penn Medicine News.

Growing body of evidence supports use of mind-body therapies in breast cancer treatment

In newly updated clinical guidelines from the Society for Integrative Oncology (SIO), researchers at Columbia University's Mailman School of Public Health and the Herbert Irving Comprehensive Cancer Center with an interdisciplinary team of colleagues at MD Anderson Cancer Center, University of Michigan, Memorial Sloan Kettering Cancer Center, and other institutions in the U.S. and Canada, analyzed which integrative treatments are most effective and safe for patients with breast cancer.

Annual Fecal Immunochemical Test Effective for Colorectal Cancer Screening

Although the fecal immunochemical test is a common method for colorectal cancer screening, its acceptability and performance over several rounds of annual testing are largely unknown. Now, a large retrospective cohort study by Jensen et al assessing the fecal immunochemical test performance characteristics over four rounds of annual screening has found that the test was associated with high sensitivity for colorectal cancer, with high adherence to annual follow-up screening among initial participants.